Real World Data: Turning Volume in Value

Real World Data: Turning Volume in Value

Real World Data can benefit multiple stakeholders within the value chain in order to support the commercialisation of strategies and provide insightful analysis for differentiation, to assist with regulatory submissions and to influence the market access strategies. However, it is not without its limitations and there a number of issues related to the consistency and repeatability of real world data in the pharma industry. 

We spoke to two industry experts in order to better understand the role that RWD can play in drug development, improving patient outcomes and the speed at which products come to market. 


Please note: That all fields marked with an asterisk (*) are required.